Canalblog
Suivre ce blog Administration + Créer mon blog
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
venture
3 mai 2015

WHAT'S THE PLAN by ORA

WHAT'S THE PLAN by ORA
What's the Plan? Ora | Ophthalmology CRO - Ophthalmic Clinical Trials - Contract Research Organization - Dry Eye - Allergy We provide Preclinical and Clinical development services to the ophthalmic drug, drug delivery and medical devices industries. http://oraclinical.com...
Publicité
Publicité
23 avril 2015

Ophthalmology Innovation Summit @ASCRS, Is there an OIS effect ?

Ophthalmology Innovation Summit @ASCRS, Is there an OIS effect ?
Adresse du Blog sur itunes: https://itunes.apple.com/us/podcast/ophthalmology-innovation-podcast/id904406267?mt=2%E2%80%8B Link, Corley, Chapin discuss funding innovation and private pay opportunities Craig Simak Managing Director at Healthegy and Producer...
17 avril 2015

Amakem Therapeutics

Amakem Therapeutics
AMAKEM THERAPEUTICS Amakem is a clinical stage ophthalmology company developing innovative new treatments for serious eye conditions. The Company’s lead program is based on AMA0076, a novel, locally-acting Rho kinase (ROCK) inhibitor, in clinical development...
Publicité
Neuroptis Dry Eye Project with ML 7 (Myosin Light Chain Inhibitor)
Newsletter
Visiteurs
Depuis la création 33 342
Publicité